MannKind Corp (NASDAQ:MNKD)
| 1.08 Delayed Data As of 3:59pm ET |  +0.01 / +0.94%Today’s Change | 0.80 Today|||52-Week Range 2.01 | -16.67% Year-to-Date |
Latest MNKD News | Press Releases
| Why 4 Coronavirus-Focused Stocks Are Crushing It Today Mar 17 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.07 |
| Today’s open | 1.04 |
| Day’s range | 1.02 - 1.08 |
| Volume | 101,082 |
| Average volume (3 months) | 2,883,945 |
| Market cap | $229.3M |
Data as of 3:59pm ET, 03/30/2020
Growth & Valuation
| Earnings growth (last year) | +56.02% |
| Earnings growth (this year) | +20.74% |
| Earnings growth (next 5 years) | +33.90% |
| Revenue growth (last year) | +126.28% |
| P/E ratio | NM |
| Price/Sales | 4.00 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| STROSutro Biopharma Inc | +0.04 | +0.40% |
| STMLStemline Therapeutic... | +0.33 | +7.50% |
| ARCTArcturus Therapeutic... | -2.55 | -16.13% |
| ADROAduro Biotech Inc | -0.04 | -1.57% |
Data as of 3:59pm ET, 03/30/2020
Financials
| Next reporting date | May 6, 2020 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $63.0M |
| Annual profit (last year) | -$51.9M |
| Net profit margin | -82.34% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Westlake Village, California |
Forecasts
